Cover Image

Is the pharmaceutical industry improving with regard to access to essential medicines?

Saved in:

Bibliographic Details
Main Authors:	Hans V Hogerzeil (Author), Jayasree K Iyer (Author), Lisanne Urlings (Author), Tara Prasad (Author), Sara Brewer (Author)
Format:	Book
Published:	Elsevier, 2014-03-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Health-sector reform in China and access to essential medicines
by: Hans V Hogerzeil, et al.
Published: (2013)

Access to essential medicines in national constitutions
by: SK Perehudoff, et al.
Published: (2010)

Access to hepatitis C medicines
by: Danny J Edwards, et al.
Published: (2015)

Essential medicines and human rights: what can they learn from each other?
by: Hogerzeil Hans V
Published: (2006)

Essential medicines and human rights: what can they learn from each other?
by: Hans V Hogerzeil

Twenty-five years of essential medicines
by: Jonathan D. Quick, et al.

Is the Brazilian pharmaceutical policy ensuring population access to essential medicines?
by: Bertoldi Andréa, et al.
Published: (2012)

A review of promoting access to medicines in China - problems and recommendations
by: Jing Sun, et al.
Published: (2018)

Public reporting on pharmaceutical industry-led access programs: alignment with the WHO medicine programs evaluation checklist
by: Chukwuemeka A. Umeh, et al.
Published: (2020)

Access to innovative cancer medicines in a middle-income country - the case of Mexico
by: Daniela Moye-Holz, et al.
Published: (2018)

UN MILLENNIUM DEVELOPMENT GOALS INDICATORS ON PROBLEMS OF ACCESS TO ESSENTIAL MEDICINES AND ENHANCEMENT OF LOCAL PHARMACEUTICAL PRODUCER IN DEVELOPING COUNTRIES
by: A. Y. Kulikov, et al.
Published: (2015)

Access and use of WHO essential medicines in Italy
by: Alessandro Petrella, et al.
Published: (2023)

Access to medicines: relations with the institutionalization of pharmaceutical services
by: Rafael Damasceno de Barros, et al.
Published: (2017)

Effects of Law Regarding Prevention of Dishonest Solicitation on the Korean Pharmaceutical Industry
by: SungMan Yoon
Published: (2021)

Proposed changes to the reimbursement of pharmaceuticals and medical devices in Poland and their impact on market access and the pharmaceutical industry
by: Karolina Badora, et al.
Published: (2017)

Conceptualisation and Role of Market Access in Pharmaceutical Industry: A Scoping Review
by: Clara Fatoye, et al.
Published: (2024)

Innovations in pharmaceutical policies and learnings for sustainable access to affordable medicines
by: Sabine Vogler, et al.
Published: (2024)

Policy approaches to improve availability and affordability of medicines in Mexico - an example of a middle income country
by: Daniela Moye-Holz, et al.
Published: (2017)

Assessment of primary labeling of medicines manufactured by Nepalese pharmaceutical industries
by: Ramesh Sharma Poudel, et al.
Published: (2018)

Accessibility of essential anticancer medicines for children in the Sichuan Province of China
by: Zhe Chen, et al.
Published: (2022)

Human resources health supply chains and access to essential medicines
by: Andrew Brown, et al.
Published: (2014)

Noncommunicable diseases, access to essential medicines and universal health coverage
by: David Beran, et al.
Published: (2019)

Availability, prices, and affordability of selected essential cancer medicines in a middle-income country - the case of Mexico
by: Daniela Moye-Holz, et al.
Published: (2020)

Promoting local production and active pharmaceutical ingredient (API) industry in low and middle income countries (LMICs): impact on medicines access and policy
by: Muhammad Akhtar Abbas Khan, et al.
Published: (2024)

Access to essential medicines for diabetes care: availability, price, and affordability in central Ethiopia
by: Hachalu Dugasa Deressa, et al.
Published: (2024)

Can NGOs regulate medicines markets? Social enterprise in wholesaling, and access to essential medicines
by: Chaudhuri Sudip, et al.
Published: (2011)

Evaluation of Pharmacy Model in a Trial of Free Essential Medicine Access
by: Muhamad Z. Ally, et al.
Published: (2020)

Access to Medicines and Pharmaceutical Policy in Saudi Arabia: A Scoping Review
by: Mirza AH, et al.
Published: (2023)

Are Turkish pharmaceutical pricing strategies an access barrier to oncology medicines for Türkiye?
by: Elif Hilal Vural, et al.
Published: (2024)

Perspectives of pharmaceutical stakeholders on determinants of medicines accessibility at the primary care level
by: Hoda Ibrahim Rizk, et al.
Published: (2021)

Commercial and Social Value of Pharmaceutical Industry-led Access Programs: Conceptual Framework and Descriptive Analysis
by: Joshua Smith-Sreen, et al.
Published: (2022)

Improving Access to COVID-19 Vaccines: An Analysis of TRIPS Waiver Discourse among WTO Members, Civil Society Organizations, and Pharmaceutical Industry Stakeholders
by: Jillian Kohler, et al.
Published: (2020)

Assessment of generic medicines development and entry decisions by the malaysian generic pharmaceutical industries
by: Omotayo Fatokun, et al.
Published: (2012)

Access to Essential Medicines and Diagnostic Tests for Cardiovascular Diseases in Maputo City, Mozambique
by: Neusa Jessen, et al.
Published: (2023)

Enabling access to new WHO essential medicines: the case for nicotine replacement therapies
by: Cravioto Alejandro, et al.
Published: (2010)

How and why pharmaceutical reforms contribute to universal health coverage through improving equitable access to medicines: a case of Ghana
by: Augustina Koduah
Published: (2023)

Availability of essential medicines and pharmaceutical inventory management practice at health centers of Adama town, Ethiopia
by: Adane Teshome Kefale, et al.
Published: (2019)

Attitudes and beliefs regarding complementary and alternative medicine in a diverse gynecologic oncology patient population
by: Emily A. Miller, et al.
Published: (2023)

Commitment to Impact: Strengthening Measurement of Industry-Led Access-to-Medicines Programs
by: Peter C. Rockers, et al.
Published: (2018)

Strategies for patient empowerment through the promotion of medicines in Israel: regulatory framework for the pharmaceutical industry
by: Eyal Schwartzberg, et al.
Published: (2017)